FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952464799> ?p ?o ?g. }

• W2952464799 endingPage "175628481985805" @default.
• W2952464799 startingPage "175628481985805" @default.
• W2952464799 abstract "Background: Several studies have reported positive efficacy outcomes for patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar. Data from follow-up periods longer than 1 year are still scarce. Here, we assessed the long-term efficacy data, loss of response and safety after switching from infliximab to CT-P13 in patients with inflammatory bowel disease. Methods: This was a prospective single-center observational study involving patients with moderate-to-severe Crohn’s disease and ulcerative colitis switched from infliximab to CT-P13 treatment and reviewed up to 24 months. Efficacy and loss of response were measured using the Harvey–Bradshaw (HB) index and partial Mayo score for patients with Crohn’s disease and ulcerative colitis respectively. C-reactive protein, infliximab drug levels, adverse events and antidrug antibodies were also monitored throughout the study. Results: A total of 64 patients with Crohn’s disease and 36 patients with ulcerative colitis were included. Most of them (72%) remained on CT-P13. Overall, 28% of patients discontinued the therapy due to loss of response, adverse events or long-lasting clinical remission. Remission at 18 and 24 months occurred in 69.9% and 68.5% of patients, respectively. Dose increase was performed in 22% of patients, with remission being reached in 60% of them. HB index, partial Mayo score, C-reactive protein and infliximab drug levels did not show significant changes. Serious adverse events were reported in 14% of patients. Overall, two patients developed low levels of antidrug antibodies. Conclusions: Most of the patients switching from original infliximab were maintained on CT-P13 at 2 years of follow up with a good profile of efficacy and safety." @default.
• W2952464799 created "2019-06-27" @default.
• W2952464799 creator A5002691024 @default.
• W2952464799 creator A5011423792 @default.
• W2952464799 creator A5021648954 @default.
• W2952464799 creator A5026512850 @default.
• W2952464799 creator A5030459018 @default.
• W2952464799 creator A5051057234 @default.
• W2952464799 creator A5051793709 @default.
• W2952464799 creator A5057831278 @default.
• W2952464799 creator A5062280141 @default.
• W2952464799 creator A5081520322 @default.
• W2952464799 date "2019-01-01" @default.
• W2952464799 modified "2023-10-17" @default.
• W2952464799 title "Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data" @default.
• W2952464799 cites W1594887498 @default.
• W2952464799 cites W1980282196 @default.
• W2952464799 cites W1997106678 @default.
• W2952464799 cites W2005855555 @default.
• W2952464799 cites W2020859458 @default.
• W2952464799 cites W2026116536 @default.
• W2952464799 cites W2072640801 @default.
• W2952464799 cites W2110327661 @default.
• W2952464799 cites W2121050884 @default.
• W2952464799 cites W2123341391 @default.
• W2952464799 cites W2130173462 @default.
• W2952464799 cites W2162768160 @default.
• W2952464799 cites W2171297959 @default.
• W2952464799 cites W2171341132 @default.
• W2952464799 cites W2308369648 @default.
• W2952464799 cites W2313671791 @default.
• W2952464799 cites W2322840961 @default.
• W2952464799 cites W2410520654 @default.
• W2952464799 cites W2560455300 @default.
• W2952464799 cites W2578994901 @default.
• W2952464799 cites W2589358629 @default.
• W2952464799 cites W2593923237 @default.
• W2952464799 cites W2605818772 @default.
• W2952464799 cites W2613299853 @default.
• W2952464799 cites W2733544055 @default.
• W2952464799 cites W2751387666 @default.
• W2952464799 cites W2801351505 @default.
• W2952464799 cites W2806215443 @default.
• W2952464799 cites W2896737472 @default.
• W2952464799 cites W2913878532 @default.
• W2952464799 cites W2982395127 @default.
• W2952464799 cites W4246739685 @default.
• W2952464799 doi "https://doi.org/10.1177/1756284819858052" @default.
• W2952464799 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6585238" @default.
• W2952464799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31258621" @default.
• W2952464799 hasPublicationYear "2019" @default.
• W2952464799 type Work @default.
• W2952464799 sameAs 2952464799 @default.
• W2952464799 citedByCount "10" @default.
• W2952464799 countsByYear W29524647992019 @default.
• W2952464799 countsByYear W29524647992020 @default.
• W2952464799 countsByYear W29524647992021 @default.
• W2952464799 countsByYear W29524647992022 @default.
• W2952464799 crossrefType "journal-article" @default.
• W2952464799 hasAuthorship W2952464799A5002691024 @default.
• W2952464799 hasAuthorship W2952464799A5011423792 @default.
• W2952464799 hasAuthorship W2952464799A5021648954 @default.
• W2952464799 hasAuthorship W2952464799A5026512850 @default.
• W2952464799 hasAuthorship W2952464799A5030459018 @default.
• W2952464799 hasAuthorship W2952464799A5051057234 @default.
• W2952464799 hasAuthorship W2952464799A5051793709 @default.
• W2952464799 hasAuthorship W2952464799A5057831278 @default.
• W2952464799 hasAuthorship W2952464799A5062280141 @default.
• W2952464799 hasAuthorship W2952464799A5081520322 @default.
• W2952464799 hasBestOaLocation W29524647991 @default.
• W2952464799 hasConcept C126322002 @default.
• W2952464799 hasConcept C197934379 @default.
• W2952464799 hasConcept C2777138892 @default.
• W2952464799 hasConcept C2778260677 @default.
• W2952464799 hasConcept C2779134260 @default.
• W2952464799 hasConcept C2779280984 @default.
• W2952464799 hasConcept C2780479503 @default.
• W2952464799 hasConcept C59491497 @default.
• W2952464799 hasConcept C71924100 @default.
• W2952464799 hasConcept C90924648 @default.
• W2952464799 hasConceptScore W2952464799C126322002 @default.
• W2952464799 hasConceptScore W2952464799C197934379 @default.
• W2952464799 hasConceptScore W2952464799C2777138892 @default.
• W2952464799 hasConceptScore W2952464799C2778260677 @default.
• W2952464799 hasConceptScore W2952464799C2779134260 @default.
• W2952464799 hasConceptScore W2952464799C2779280984 @default.
• W2952464799 hasConceptScore W2952464799C2780479503 @default.
• W2952464799 hasConceptScore W2952464799C59491497 @default.
• W2952464799 hasConceptScore W2952464799C71924100 @default.
• W2952464799 hasConceptScore W2952464799C90924648 @default.
• W2952464799 hasLocation W29524647991 @default.
• W2952464799 hasLocation W29524647992 @default.
• W2952464799 hasLocation W29524647993 @default.
• W2952464799 hasLocation W29524647994 @default.
• W2952464799 hasLocation W29524647995 @default.
• W2952464799 hasOpenAccess W2952464799 @default.
• W2952464799 hasPrimaryLocation W29524647991 @default.
• W2952464799 hasRelatedWork W1576589857 @default.

• next